C. Sahaya Pushpa Sarmila Star , T.M. Inbamalar , A. Milton
{"title":"Automatic semantic segmentation of breast cancer in DCE-MRI using DeepLabV3+ with modified ResNet50","authors":"C. Sahaya Pushpa Sarmila Star , T.M. Inbamalar , A. Milton","doi":"10.1016/j.bspc.2024.106691","DOIUrl":null,"url":null,"abstract":"<div><div>Research on breast cancer segmentation is essential due to its high prevalence as the most common cancer in women and its occurrence in men as well. Breast cancer involves abnormal cell growth in the breast, highlighting the importance of advanced imaging. Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) is an effective technique for this purpose. Deep learning has significantly influenced medical imaging in recent years, especially in accurately segmenting tumors from MRI images. Two techniques have been proposed for breast tumor segmentation: Dilated ResNet50 (RN50D) and Parallel Layers Added ResNet50 (PLA-RN50). RN50D involves altering the dilation factor of the convolution layer within the residual block of ResNet50. PLA-RN50 entails the integration of parallel layers following the final residual block of the ResNet50 architecture. The modified architectures serve as the backbone for the DeepLabV3+ network. The DeepLabV3+ with RN50D or PLA-RN50D is a powerful and effective architecture that integrates deep feature extraction, multiscale spatial information, and precise segmentation to achieve high accuracy in lesion segmentation for breast DCE-MRI images. The proposed technique is tested on a QIN Breast DCE-MRI dataset comprising 233 images sourced from The Cancer Image Archive. The proposed method achieves a dice score of 0.92. The superior segmentation performance of DeepLabV3+ with PLA-RN50, as compared to its counterparts using ResNet18 and ResNet50, highlights the impactful modifications incorporated in PLA-RN50 for optimizing breast tumor segmentation.</div></div>","PeriodicalId":55362,"journal":{"name":"Biomedical Signal Processing and Control","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Signal Processing and Control","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1746809424007493","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Research on breast cancer segmentation is essential due to its high prevalence as the most common cancer in women and its occurrence in men as well. Breast cancer involves abnormal cell growth in the breast, highlighting the importance of advanced imaging. Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) is an effective technique for this purpose. Deep learning has significantly influenced medical imaging in recent years, especially in accurately segmenting tumors from MRI images. Two techniques have been proposed for breast tumor segmentation: Dilated ResNet50 (RN50D) and Parallel Layers Added ResNet50 (PLA-RN50). RN50D involves altering the dilation factor of the convolution layer within the residual block of ResNet50. PLA-RN50 entails the integration of parallel layers following the final residual block of the ResNet50 architecture. The modified architectures serve as the backbone for the DeepLabV3+ network. The DeepLabV3+ with RN50D or PLA-RN50D is a powerful and effective architecture that integrates deep feature extraction, multiscale spatial information, and precise segmentation to achieve high accuracy in lesion segmentation for breast DCE-MRI images. The proposed technique is tested on a QIN Breast DCE-MRI dataset comprising 233 images sourced from The Cancer Image Archive. The proposed method achieves a dice score of 0.92. The superior segmentation performance of DeepLabV3+ with PLA-RN50, as compared to its counterparts using ResNet18 and ResNet50, highlights the impactful modifications incorporated in PLA-RN50 for optimizing breast tumor segmentation.
期刊介绍:
Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.
Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.